These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 11960197

  • 1. Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats.
    Santos JG, Do Monte FH, Russi M, Agustine PE, Lanziotti VM.
    Braz J Med Biol Res; 2002 Apr; 35(4):469-72. PubMed ID: 11960197
    [Abstract] [Full Text] [Related]

  • 2. Seizures associated with therapeutic doses of venlafaxine and trimipramine.
    Schlienger RG, Klink MH, Eggenberger C, Drewe J.
    Ann Pharmacother; 2000 Dec; 34(12):1402-5. PubMed ID: 11144696
    [Abstract] [Full Text] [Related]

  • 3. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
    de Carvalho CR, Hoeller AA, Franco PL, Martini AP, Soares FM, Lin K, Prediger RD, Whalley BJ, Walz R.
    Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
    [Abstract] [Full Text] [Related]

  • 4. Seizure activity and enzyme elevations after venlafaxine overdose.
    Zhalkovsky B, Walker D, Bourgeois JA.
    J Clin Psychopharmacol; 1997 Dec; 17(6):490-1. PubMed ID: 9408815
    [No Abstract] [Full Text] [Related]

  • 5. Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders.
    Zimmer B, Kant R, Zeiler D, Brilmyer M.
    Int J Psychiatry Med; 1997 Dec; 27(4):353-64. PubMed ID: 9565731
    [Abstract] [Full Text] [Related]

  • 6. Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications.
    Vanoli A, Lane C, Harrison C, Steen N, Young A.
    J Psychopharmacol; 2008 Jun; 22(4):434-40. PubMed ID: 18635723
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models.
    Vermoesen K, Serruys AS, Loyens E, Afrikanova T, Massie A, Schallier A, Michotte Y, Crawford AD, Esguerra CV, de Witte PA, Smolders I, Clinckers R.
    Epilepsy Behav; 2011 Nov; 22(3):450-60. PubMed ID: 21962757
    [Abstract] [Full Text] [Related]

  • 8. Low-dose venlafaxine-induced severe rhabdomyolysis: a case report.
    Huang SS, Yang HY, Lin YC, Chan CH.
    Gen Hosp Psychiatry; 2012 Nov; 34(4):436.e5-7. PubMed ID: 22459996
    [Abstract] [Full Text] [Related]

  • 9. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW, Aikman MS, Werts E, Seabolt J, Haeusler JM.
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [Abstract] [Full Text] [Related]

  • 10. Venlafaxine.
    Shuster J.
    Nursing; 1996 Mar; 26(3):27. PubMed ID: 8700462
    [No Abstract] [Full Text] [Related]

  • 11. Venlafaxine-associated interstitial pneumonitis.
    Turner RC, Nelson JE, Roberts BT, Gillam DM.
    Pharmacotherapy; 2005 Apr; 25(4):626-9. PubMed ID: 15977923
    [Abstract] [Full Text] [Related]

  • 12. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats.
    Dhediya RM, Joshi SS, Gajbhiye SV, Jalgaonkar SV, Biswas M.
    Epilepsy Behav; 2016 Aug; 61():153-157. PubMed ID: 27344504
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats.
    Ceyhan M, Kayir H, Uzbay IT.
    J Psychiatr Res; 2005 Mar; 39(2):191-6. PubMed ID: 15589568
    [Abstract] [Full Text] [Related]

  • 15. Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models.
    Bankstahl M, Bankstahl JP, Bloms-Funke P, Löscher W.
    Neurotoxicology; 2012 Jan; 33(1):127-37. PubMed ID: 22209701
    [Abstract] [Full Text] [Related]

  • 16. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD, Shults J.
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [Abstract] [Full Text] [Related]

  • 17. Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.
    Alexandrino-Silva C, Nadalini Mauá FH, de Andrade AG, de Toledo Ferraz Alves TC.
    J Psychopharmacol; 2008 Mar; 22(2):214-6. PubMed ID: 18208934
    [Abstract] [Full Text] [Related]

  • 18. An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms.
    Reznik I, Rosen Y, Rosen B.
    J Psychopharmacol; 1999 Mar; 13(2):193-5. PubMed ID: 10475726
    [Abstract] [Full Text] [Related]

  • 19. The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains.
    Watanabe M, Miyai A, Danjo S, Nakamura Y, Itoh K.
    Exp Neurol; 2013 Sep; 247():645-52. PubMed ID: 23499834
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression.
    Gonzalez-Pinto A, Gutierrez M, Gonzalez N, Elizagarate E, Perez de Heredia JL, Mico JA.
    J Neuropsychiatry Clin Neurosci; 2002 Sep; 14(2):206-9. PubMed ID: 11983797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.